Watch, Read,
Unmasked

Everything in one place — every episode, its companion article, and written deep dives. Filter by what you're in the mood for.

The Harvard Blueprint for Non-Profit Scaling EP 15 TBD
DS
Donald Summers

The Harvard Blueprint for Non-Profit Scaling

How does a literature scholar transition into an elite leadership program at Harvard, completely reshape his worldview on corporate frameworks, and bu...

From Fired Art Student to Global Tech CEO EP 14 TBD
DS
Douglas Sapp

From Fired Art Student to Global Tech CEO

What happens when you graduate from art school with a degree you don't care about and get promptly fired from your very first job just five months in?...

15 Years of High-Stakes HR and Operational Strategy EP 13 TBD
SS
Sarah Seale

15 Years of High-Stakes HR and Operational Strategy

Why do standard human resource consultants and recruitment firms completely fail when entering complex, hyper-regulated international fields? Sarah Se...

From General to Executive Coach EP 12 TBD
RM
Robert Mixon

From General to Executive Coach

How do you translate decades of elite, high-stakes military command into an operational framework that allows modern corporations to scale under press...

From Mechanical Engineer to Hedge Fund CEO EP 11 TBD
TR
Timothy Rose

From Mechanical Engineer to Hedge Fund CEO

Most aspiring financiers believe a Harvard MBA is the only ticket to the top, but Timothy Rose proves that common sense often outruns a PhD. As the CE...

How to Scale an AI-First Tech Services Venture in 2026 EP 10 TBD
AS
Aater Suleman

How to Scale an AI-First Tech Services Venture in 2026

Is building a SaaS product actually a trap for highly technical founders? Aater Suleman, the former computer architecture professor at UT Austin and c...

From Failed IPO to Funding a Global Gaming Infrastructure Play EP 09 TBD
J
Jasim

From Failed IPO to Funding a Global Gaming Infrastructure Play

After a failed IPO attempt during Covid, Jasim, known as Jay, rebuilt his strategy and raised capital to launch PlaysOut, a gaming infrastructure comp...

Article VenuPlus Read →
CF
Cihan Fuat Atkin

Why Hollywood Hates the Idea of Paying Per Viewer

Cihan Fuat Atkin spent a decade building per-viewer ticketing for streaming. Hollywood blocked it. So he flipped the script and built VenuPlus — giving creators back the data, the audience, and the money.

Zero Marketing Spend to 4M Users EP 07 29:24
Y
Yogesh

Zero Marketing Spend to 4M Users: The B2B Health AI Playbook

How a B2B health AI company reached 4 million users without spending a dollar on marketing.

How to Automate a $3 Trillion Manufacturing Market EP 06 33:18
D
Daniele

How to Automate a $3 Trillion Manufacturing Market

Materials physicist turned 5x entrepreneur building Physical AI — robots that assemble parts with human-like intuition. Backed by a $1M no-equity grant.

Why Every Deep Tech Founder Needs a Media Engine EP 05 24:38
ML
Mitchell Leshchiner

Why Every Deep Tech Founder Needs a Media Engine

Ex-pro soccer player, ex-Palantir engineer building ElectroCare — AI-powered continuous blood biomarker tracking. Mission: save a million lives.

How He Raised $3M for his Biotech Startup EP 04 39:20
FK
Franco Kraiselburd

How He Raised $3M for his Biotech Startup

23-year-old CEO of Asclepi reinventing the Band-Aid with next-gen wound care. Raised $3M — half through non-dilutive grants.

From Napkin to $1M ARR EP 03 20:17
RB
Robert Brennan

From Napkin to $1M ARR: The Playbook for Monetizing Free Software

Co-founder of All Hands AI secured $18M in seed funding after open-source AI coding tool exploded on GitHub. From Google to the future of coding.

The Digital Franchise Model EP 02 25:39
AA
Ammar Akhtar

The Digital Franchise Model: 500x Growth in Three Years

The "Uber of car rentals" — scaled to 60 countries without owning a single car. From Karachi to Dubai to the world.

Why I Bought My Competitor EP 01 28:03
SB
Somer Baburek

Why I Bought My Competitor Instead of Fighting Them

From barrel racer to VC to biotech CEO — used the corporate rollup strategy to fast-track Hera Biotech in women's health.